DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C1864100 | PSEUDOHYPOPARATHYROIDISM, TYPE IB | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0085084 | Motor Neuron Disease | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C1851584 | Childhood Ependymoma | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0023521 | Globoid cell leukodystrophy | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0037822 | Speech Disorders | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0032285 | Pneumonia | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0158981 | Neonatal diabetes mellitus | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0004903 | Beckwith-Wiedemann Syndrome | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C1458155 | Mammary Neoplasms | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0558356 | Malignant melanoma of eye | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0014474 | Ependymoma | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0029456 | Osteoporosis | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0007113 | Rectal Carcinoma | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0699790 | Colon Carcinoma | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0020456 | Hyperglycemia | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0002395 | Alzheimer's Disease | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0041408 | Turner Syndrome | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
C0020538 | Hypertensive disease | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0085413 | Polycystic Kidney, Autosomal Dominant | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0022661 | Kidney Failure, Chronic | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C2751306 | Polycystic kidney disease, type 2 | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C4552000 | Episodic Kinesigenic Dyskinesia 1 | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C3887499 | Renal cyst | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0022680 | Polycystic Kidney Diseases | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0006826 | Malignant Neoplasms | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024